Latest From Biotech Now

FDA Safety and Innovation Act: A Step Forward for Patients With Rare Diseases

Peter L. Saltonstall

By Peter L. Saltonstall, President and CEO, National Organization for Rare Disorders (NORD) The Food and Drug Administration Safety and Innovation Act (FDASIA) includes the most groundbreaking measures for rare disease patients and their families since the Orphan Drug Act of 1983.  And, just as the rare disease patient community—with NORD as its unifying voice—played a major role in the Orphan Drug Act, NORD and rare disease patients have taken a leadership role in developing Read More >

Health  |  13 Comments  |  Email This Post
Tags: , , , , , , , , ,

Indices, IPOs, and New Drug Approvals – Update July 6th 2012

Index-Perfomance-June-2012-thumb

1. Stock Performance. The Nasdaq Biotech Index (NBI) continued on its path of outperforming the market, up 24.6 percent and increasing its Year-to-Date (YTD) lead over the S&P 500 which is up 8.3 percent. The Amex Biotech Index (BTK) closed out June up a hefty 34.6 percent YTD: 2. IPOs: Tesaro, Inc. (TSRO) was June’s sole U.S. IPO, raising $81M.  The company was formed just two years ago and has aggressively in-licensed cancer treatments from Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

See for Yourself: New BIO Book Showcases Visible Progress in Industrial Biotech

biofuel-plant-btn

BIO recently introduced a picture book of biorefineries across the United States, “Visible Progress in Commercialization of Advanced Biofuels, Biobased Products and Renewable Chemicals”, which showcases commercial, demonstration and even new pilot facilities. Some of these facilities have been in operation for as long as a decade while others are new plants under construction. They include the first commercial-scale cellulosic biofuel production biorefineries and facilities for ongoing research and development of industrial biotech products. Biorefineries Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , ,

Vaccines Beyond 2012

polio-vaccine

Each year, approximately 1.7 million children die from a vaccine-preventable disease, and the vast majority of these deaths occur in developing countries. This BIO 2012 session, moderated by Peg Willingham of the United Nations Foundation, addressed various ways industry can help increase access to life-saving vaccines for children and adults in resource-poor countries. The thoughts of a few of the speakers on the panel for this session are summarized below. The panelists suggested that for Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Telling the Biotech Story at the BIO International Convention

convention-ribbon

The global event for biotechnology wrapped up last week at the Boston Convention & Exhibition Center in Boston, Mass. The event was a huge success, with a record 25,291 partnering meetings and hundreds of high-level speakers addressing critical global challenges and opportunities. More than 16,500 industry leaders from 49 states and 65 countries attended, yet again earning the title as the largest biotechnology event in the world. People are always asking for my perspective on our Convention, Read More >

Jim's Corner  |  1 Comment  |  Email This Post
Tags: , , , , ,